Robust Protocol for the Synthesis of BSA Nanohydrogels by Inverse Nanoemulsion for Drug Delivery
Langmuir · 13.06.2023 · 39 (23) · 8176-8185
DOI: 10.1021/acs.langmuir.3c00635 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Langmuir, online erschienen am 29.05.2023. Verfasst von Susanne Sihler und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Organic Chemistry III-Macromolecular Chemistry and Organic Materials, University of Ulm, Albert-Einstein-Allee 11, Ulm 89081, Germany. Hauptthemen laut MEDLINE: Serum Albumin, Bovine, Drug Delivery Systems. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
In a highly efficient and reproducible process, bovine serum albumin (BSA) nanogels are prepared from inverse nanoemulsions. The concept of independent nanoreactors of the individual droplets in the nanoemulsions allows high protein concentrations of up to 0.6% in the inverse total system. The BSA gel networks are generated by the 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride coupling strategy widely used in protein chemistry. In a robust work-up protocol, the hydrophobic continuous phase of the inverse emulsion is stepwise replaced by water without compromising the colloidal stability and non-toxicity of the nanogel particles. Further, the simple process allows the loading of the nanogels with various cargos like a dye (Dy-495), a drug (ibuprofen), another protein [FMN-binding fluorescent protein (EcFbFP)], and oligonucleotides [plasmid DNA for enhanced GFP expression in mammalian cells (pEGFP c3) and a synthetic anti-Pseudomonas aeruginosa aptamer library]. These charged nanoobjects work efficiently as carriers for staining and transfection of cells. This is exemplarily shown for a phalloidin dye and a plasmid DNA as cargo with adenocarcinomic human alveolar basal epithelial cells (A549), a cell revertant of the SV-40 cancer rat cell line SV-52 (Rev2), and human breast carcinoma cells (MDA-MB-231), respectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Organic Chemistry III-Macromolecular Chemistry and Organic Materials, University of Ulm, Albert-Einstein-Allee 11, Ulm 89081, Germany.
- Institute of Pharmaceutical Biotechnology, University of Ulm, Albert-Einstein-Allee 11, Ulm 89081, Germany.
- Department of Life Sciences, Albstadt-Sigmaringen University of Applied Sciences, Sigmaringen 72488, Germany.
- Department Synthesis of Macromolecules, Max Planck Institute for Polymer Research, Mainz 55128, Germany.
ORCID-Profile: Frank Rosenau, Ulrich Ziener
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Sihler, S., Krämer, M., Schmitt, F., Favella, P., Mützel, L., Baatz, J., Rosenau, F., & Ziener, U. (2023). Robust Protocol for the Synthesis of BSA Nanohydrogels by Inverse Nanoemulsion for Drug Delivery. Langmuir, 39(23), 8176-8185. https://doi.org/10.1021/acs.langmuir.3c00635
Vancouver
Sihler S, Krämer M, Schmitt F, Favella P, Mützel L, Baatz J, et al. Robust Protocol for the Synthesis of BSA Nanohydrogels by Inverse Nanoemulsion for Drug Delivery. Langmuir. 2023;39(23):8176-8185. doi:10.1021/acs.langmuir.3c00635
BibTeX
@article{Sihler2023,
author = {Sihler, Susanne and Krämer, Markus and Schmitt, Felicitas and Favella, Patrizia and Mützel, Laura and Baatz, Jennifer and Rosenau, Frank and Ziener, Ulrich},
title = {Robust Protocol for the Synthesis of BSA Nanohydrogels by Inverse Nanoemulsion for Drug Delivery},
journal = {Langmuir},
year = {2023},
volume = {39},
number = {23},
pages = {8176--8185},
doi = {10.1021/acs.langmuir.3c00635}
}
EUVIMED